A detailed history of Morgan Stanley transactions in Pulmonx Corp stock. As of the latest transaction made, Morgan Stanley holds 2,651,445 shares of LUNG stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,651,445
Previous 2,278,721 16.36%
Holding current value
$16.8 Million
Previous $29.1 Million 15.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$8.71 - $14.65 $3.25 Million - $5.46 Million
372,724 Added 16.36%
2,651,445 $24.6 Million
Q4 2023

Feb 13, 2024

BUY
$7.89 - $13.14 $464,681 - $773,880
58,895 Added 2.65%
2,278,721 $29.1 Million
Q3 2023

Nov 15, 2023

BUY
$9.88 - $14.0 $2.43 Million - $3.45 Million
246,302 Added 12.48%
2,219,826 $22.9 Million
Q2 2023

Aug 14, 2023

SELL
$10.78 - $13.65 $6.91 Million - $8.75 Million
-640,847 Reduced 24.51%
1,973,524 $25.9 Million
Q1 2023

May 15, 2023

BUY
$7.49 - $12.54 $3.47 Million - $5.82 Million
463,866 Added 21.57%
2,614,371 $29.2 Million
Q4 2022

Feb 14, 2023

BUY
$4.92 - $17.35 $1.46 Million - $5.15 Million
296,682 Added 16.0%
2,150,505 $18.1 Million
Q3 2022

Nov 14, 2022

SELL
$15.35 - $23.99 $4.21 Million - $6.57 Million
-273,948 Reduced 12.87%
1,853,823 $30.9 Million
Q2 2022

Oct 27, 2022

BUY
$14.0 - $27.95 $26.6 Million - $53 Million
1,897,698 Added 824.82%
2,127,771 $31.3 Million
Q2 2022

Aug 15, 2022

BUY
$14.0 - $27.95 $26.6 Million - $53 Million
1,897,698 Added 824.82%
2,127,771 $31.3 Million
Q1 2022

Oct 27, 2022

SELL
$21.13 - $35.65 $40.1 Million - $67.7 Million
-1,897,698 Reduced 89.19%
230,073 $5.71 Million
Q1 2022

May 13, 2022

BUY
$21.13 - $35.65 $3.44 Million - $5.81 Million
163,024 Added 243.14%
230,073 $5.71 Million
Q4 2021

Feb 14, 2022

BUY
$29.72 - $45.1 $1.43 Million - $2.17 Million
48,171 Added 255.17%
67,049 $2.15 Million
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $679,230 - $839,693
18,878 New
18,878 $680,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.